首页> 外文期刊>European Journal of Pharmacology: An International Journal >Amphetamine enhances Ca(2+) entry and catecholamine release via nicotinic receptor activation in bovine adrenal chromaffin cells.
【24h】

Amphetamine enhances Ca(2+) entry and catecholamine release via nicotinic receptor activation in bovine adrenal chromaffin cells.

机译:安非他明通过牛肾上腺嗜铬细胞的烟碱样受体激活增强了Ca(2+)进入和儿茶酚胺的释放。

获取原文
获取原文并翻译 | 示例
           

摘要

Amphetamine, a psychostimulant, has been shown to act as a channel blocker of muscle nicotinic receptors and to induce a Ca(2+)-dependent secretion from adrenal chromaffin cells. In this study, the relationship between amphetamine and nicotinic receptors was studied using bovine adrenal chromaffin cells as a model system. Our results show that D-amphetamine sulfate alone induced an increase in the cytosolic Ca(2+) concentration ([Ca(2+)](c)) and [3H]norepinephrine release in a dose-dependent and extracellular Ca(2+)-dependent manner. Two common nicotinic receptor antagonists, hexamethonium and mecamylamine, suppressed the D-amphetamine sulfate-induced [Ca(2+)](c) rise and [3H]norepinephrine release. In addition, D-amphetamine sulfate inhibited the 1,1-dimethyl-4-phenyl-piperazinium iodide (DMPP)-induced [Ca(2+)](c) rise and [3H]norepinephrine release, but not the high K(+)- or veratridine-induced [Ca(2+)](c) increase and [3H]norepinephrine release. Antagonists, including alpha-bungarotoxin and choline,that are more specific for alpha7 nicotinic receptors were capable of inhibiting the D-amphetamine sulfate-induced [Ca(2+)](c) rise, while D-amphetamine sulfate was found to be capable of inhibiting the [Ca(2+)](c) rise induced by the alpha7-nicotinic receptor agonists, epibatidine and choline. Moreover, D-amphetamine sulfate dose-dependently suppressed [3H]nicotine binding to chromaffin cells. We, therefore, conclude that D-amphetamine sulfate acts as a nicotinic receptor agonist to induce [Ca(2+)](c) increase and [3H]norepinephrine release in bovine adrenal chromaffin cells.
机译:苯丙胺,一种精神刺激药,已被证明可充当肌肉烟碱受体的通道阻滞剂,并诱导肾上腺嗜铬细胞的Ca(2+)依赖性分泌。在这项研究中,以牛肾上腺嗜铬细胞为模型系统研究了苯丙胺与烟碱样受体之间的关系。我们的结果表明,单独的D-苯异丙胺硫酸盐诱导细胞溶质Ca(2+)浓度([Ca(2 +)](c))和[3H]去甲肾上腺素的释放呈剂量依赖性和细胞外Ca(2+ )依赖方式。两种常见的烟碱类受体拮抗剂,六甲铵和美卡敏,抑制了D-苯异丙胺硫酸盐诱导的[Ca(2 +)](c)升高和[3H]去甲肾上腺素释放。此外,D-苯异丙胺硫酸盐可抑制1,1-二甲基-4-苯基碘化哌嗪酮(DMPP)诱导的[Ca(2 +)](c)升高和[3H]去甲肾上腺素释放,但不抑制高K( +)-或维拉替丁诱导的[Ca(2 +)](c)增加和[3H]去甲肾上腺素释放。拮抗剂,包括对α7烟碱样受体更特异的α-真菌毒素和胆碱,能够抑制D-苯异丙胺硫酸盐诱导的[Ca(2 +)](c)升高,而发现D-苯异丙胺硫酸盐能够抑制由α7烟碱样受体激动剂,依巴替丁和胆碱引起的[Ca(2 +)](c)升高。此外,硫酸D-苯异丙胺剂量依赖性地抑制[3 H]烟碱与嗜铬细胞的结合。因此,我们得出结论,硫酸D-苯异丙胺充当烟碱样受体激动剂,可诱导牛肾上腺嗜铬细胞中[Ca(2 +)](c)增加和[3H]去甲肾上腺素释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号